Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Alfresa Pharma to Take Over Tofranil from Novartis
July 19, 2010
- Korosho to Create Subcommittee on Vaccines Not Covered by Periodic Programs
July 19, 2010
- AZ to Develop Promotional Methods Not Using MRs
July 19, 2010
- Korosho Announces Data on Subsidies Provided by Local Gov't for Vaccinations
July 19, 2010
- Shionogi Wins Patent Infringement Lawsuit over Crestor in US
July 19, 2010
- GL Published by Korosho for Evaluation of Oral Hypoglycemic Agents
July 19, 2010
- Astellas, Teva Reach Settlement Agreement on Vesicare Patent Lawsuit
July 19, 2010
- Merck to Develop Biosimilars: Dr Wiederrecht
July 19, 2010
- Some Diseases Can Be Prevented Only by Vaccines: Dr Sonobe
July 19, 2010
- MCI to Provide Contents of Online Version of NEJM
July 19, 2010
- Alliances to Be Accelerated in Drug Discovery: Dr Nishikawa of NBI
July 19, 2010
- Oxiconazole-Based OTC Drugs Approved for Vaginal Candida
July 19, 2010
- Health & Welfare Cooperative Union to Consider Joint Purchase of Drugs
July 19, 2010
- SymBio Enters PII for Bendamustine for Multiple Myeloma
July 19, 2010
- Victoza to Drive Sales of Novo Nordisk to ¥100.0 Bil.
July 19, 2010
- JMA Concerned about Promotional Use of Medical DB by Drug Firms
July 19, 2010
- Banyu to Recruit Subjects in More Prefectures for PII Trial of MK-8669
July 19, 2010
- OHARA Pharm. Licenses Erwinase from EUSA Pharma
July 19, 2010
- NEW PRODUCTS
July 19, 2010
- Torii to Enter PIII for Sublingual Desensitization Therapy for Pollinosis
July 19, 2010
ページ
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…